No correlation of depression and anxiety to plasma estrogen and progesterone levels in patients with premenstrual dysphoric disorder

Psychiatry and Clinical Neurosciences

Volumn 58, Issue 6, 2004, Pages 593-599

  Hsiao, Cheng Cheng ^a,b   Liu, Chia Yih ^a,b   Hsiao, Mei Chun ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Anxiety; Depression; Estrogen; Premenstrual dysphoric disorder; Progesterone.

Indexed keywords

ESTROGEN; PROGESTERONE;

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; ESTROGEN BLOOD LEVEL; FEMALE; HAMILTON SCALE; HUMAN; MENSTRUAL CYCLE; MOOD; PLASMA; PREMENSTRUAL DYSPHORIC DISORDER; PROGESTERONE BLOOD LEVEL; TAIWAN;

ADULT; AFFECT; ANXIETY; DEPRESSION; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; PREMENSTRUAL SYNDROME; PROGESTERONE; PSYCHIATRIC STATUS RATING SCALES;

EID: 11144235223     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2004.01308.x     Document Type: Article

References (35)

1. Korzekwa MI, Steiner M. Premenstrual syndrome. Clin. Obstet. Gynecol. 1997; 40: 564-576.
2. Pearlstein T, Stone AB. Premenstrual syndromes. Psychiatr. Clin. North. Am. 1998; 21: 577-590.
3. Endicott J, Amsterdam J, Eriksson E et al. Is premenstrual dysphoric disorder a distinct clinical entity? J. Womens Ment. Health 1999; 8: 663-679.
4. Backstrom T, Mattsson B. Correlation of symptoms in pre-menstrual tension to oestrogen and progesterone concentrations in blood plasma. A preliminary study. Neuropsychobiology 1975; 1: 80-86.
5. Zinder O, Dar DE. Neuroactive steroids: their mechanism of action and their function in the stress response. Acta. Physiol. Scand. 1999; 167: 181-188.
6. Weinstock LS. Gender differences in the presentation and management of social anxiety disorder. J. Clin. Psychiatr. 1999; 9 (Suppl. 60): 9-13.
7. Pigott TA. Gender differences in the epidemiology and treatment of anxiety disorders. J. Clin. Psychiatr. 1999; 18: 4-15.
8. Herzog AG. Psychoneuroendocrine aspects of temporolimbic epilepsy. Part I. Brain, reproductive steroids, and emotions. Psychosomatics 1999; 40: 95-101.
9. Galeeva A, Tuohimaa P. Analysis of mouse plus-maze behavior modulated by ovarian steroids. Behav. Brain Res. 2001; 119: 41-47.
10. Girdler SS, Straneva PA, Light KC, Pedersen CA, Morrow AL. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol. Psychiatr. 2001; 49: 788-797.
11. Backstrom T, Sanders D, Leask R., Davidson D, Warner P, Bancroft J. Mood, sexuality, hormone levels and their relationship to the premenstrual syndrome. Psychosom. Med. 1983; 45: 503-507.
12. Smith SL. The menstrual cycle and mood disturbances. Clin. Obstet. Gynecol. 1976; 19: 391-397.
13. Hsiao MC, Liu CY, Chen KC, Hsieh TT. Characteristics of women utilizing a mental health clinic in a gynecological outpatient setting. Psychiatr. Clin. Neurosciences 2002; 56: 459-463.
14. Hsiao MC, Liu CY, Chen KC, Hsieh TT. Characteristics of women seeking treatment for premenstrual syndrome in Taiwan. Acta. Psychiatr. Scand. 2002; 106: 150-155.
15. Sheehan DV, Lecrubier Y, Sheehan KH et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a Structured Diagnostic Psychiatric Interview for DSM-IV and ICD-10. J. Clin. Psychiatr. 1998; 59: 22-33.
16. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Press, Washington, DC, 1994.
17. Reid RL. Premenstrual Syndrome. Curr. Probl. Obstet. Gynecol. Fertil. 1985; 8: 43-67.
18. Hamilton M. The assessment of anxiety scales by rating. Br. J. Med. Psychol. 1959; 32: 50-55.
19. Spielberger CD, Borsuch RL, Lushene RE. State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto, 1970.
20. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatr. 1960; 23: 56-62.
21. de Lignieres B, Vincens M. Differential effects of exogenous oestradiol and progesterone on mood in postmenopausal women: individual dose/effect relationship. Maturitas 1982; 4: 67-72.
22. Strickler RC. Endocrine hypotheses for the etiology of premenstrual syndrome. Clin. Obstet. Gynecol. 1987; 30: 377-385.
23. Clare AW. Hormones, behaviour and the menstrual cycle. J. Psychosom. Res. 1985; 29: 225-233.
24. Frank RT. The hormonal basis of premenstrual tension. Arch. Neurol. Psychiatr. 1931; 26: 1053-1057.
25. Backstrom T, Carstensen H. Estrogen and progesterone in plasma in relation to premenstrual tension. J. Ster. Biochem. 1974; 5: 257-260.
26. Backstrom T, Wide L, Sodergard R, Carstensen H. FSH, LH, TeBG-capacity, estrogen and progesterone in women with premenstrual tension during the luteal phase. J. Ster. Biochem. 1976; 7: 473-476.
27. Greene R, Dalton K. The premenstrual syndrome. Br. Med. J. 1953; 1: 1007-1013.
28. Steiner BJ, Carroll BJ. The psychobiology of premenstrual dysphoria: review of theories and treatments. Psychoneuroendocrinology 1977; 2: 321-325.
29. Baker ER, Best RG, Manfredi RL, Demers LM, Wolf GC. Efficacy of progesterone vaginal suppositories in alleviation of nervous symptoms in patients with premenstrual syndrome. J. Assist. Reprod. Genet. 1995; 12: 205-209.
30. Dalton K. The Premenstrual Syndrome. Heinemann, London, 1964.
31. Faratian B, Gaspar A, O'Brien PM, Johnson IR, Filshie GM, Prescott P. Premenstrual syndrome: weight, abdominal swelling, and perceived body image. Am. J. Obstet. Gynecol. 1984; 150: 200-204.
32. Sundstrom Poromaa I, Smith S, Gulinello M. GABA receptors, progesterone and premenstrual dysphoric disorder. Arch. Women Ment. Health 2003; 6: 23-41.
33. Epperson CN, Haga K, Mason GF et al. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch. General Psychiatr. 2002; 59: 851-858.
34. Follesa P, Porcu P, Sogliano C et al. Changes in GABAA receptor gamma 2 subunit gene expression induced by long-term administration of oral contraceptives in rats. Neuropharmacology 2002; 42: 325-336.
35. Freeman WE, Purdy RH, Coutifaris C, Rickels K, Paul SM. Anxiolytic metabolites of progesterone: correlation with mood and performance measures following oral progesterone administration to healthy female volunteers. Neuroendocrinology 1993; 58: 478-484.